Results 91 to 100 of about 103,351 (342)

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister, Atul T. Patel, Marta Banach, Aaron Ellenbogen, Jaroslaw Slawek, Sebastian Paus, Hyder A. Jinnah, Virgilio Evidente, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +11 more
wiley   +1 more source

Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]

Journal of Fasa University of Medical Sciences, 2013
Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj   +1 more source

Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity

Acta Médica Portuguesa, 2020
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa, Inês Mendes Ribeiro, Luisa Medeiros   +2 more
doaj   +1 more source

Long-term efficacy of spasticity-corrective surgery and botulinum toxin injections for upper limb spasticity treatment

Journal of Rehabilitation Medicine - Clinical Communications
Objective: To evaluate the long-term efficacy of spasticity-corrective surgery and botulinum toxin treatment in patients with upper limb spasticity. Design: Pretest-posttest quasi-experimental study.
Therese Ramström, Johanna Wangdell, Carina Reinholdt, Trandur Ulfarsson, Lina Bunketorp Käll   +4 more
doaj   +1 more source

Botulinum Toxin Type A With Oral Baclofen Versus Oral Tizanidine: A Nonrandomized Pilot Comparison in Patients With Cerebral Palsy and Spastic Equinus Foot Deformity [PDF]

, 2008
The objective Of this Study was to compare the effectiveness of baclofen versus tizanidine as adjuvant treatment of botulinum toxin type A botulinum toxin type A in the management of children with spasticity. Thirty children with gastroenemius spasticity
Awan, Safia, Dai, Alper I., Wasay, Mohammad   +2 more
core   +2 more sources

Precisely specifying which botulinum toxin products are used for aesthetic treatments is essential

Journal of Oral Biology and Craniofacial Research, 2022
Andy Pickett
doaj   +1 more source

Functional Head Tremor: Contrasting Features with Other Tremor Etiologies

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Functional tremor (FT) is considered the most common phenomenology among patients with functional movement disorders (FMDs). Most patients have limb tremor, but they can also present with tremor involving the head and trunk. Objectives and Methods We aimed to assess the clinical phenomenology of functional head tremor (FHT) and ...
José Fidel Baizabal‐Carvallo, Joseph Jankovic   +1 more
wiley   +1 more source

The role of botulinum toxin in the treatment of diseases beyond aesthetics: migraine, hyperhidrosis and bruxism - literature review

Quality in Sport
In the 19th century, botulinum toxin was recognized solely as a poison. Subsequent research led to its medical applications, and today, it is predominantly utilized in aesthetic medicine.
Karolina Oskroba, Maciej Sokołowski, Estera Graczyk, Joanna Kryślak, Katarzyna Skibicka, Adam Solarz, Szymon Szabelski, Oliwia Cwalina, Jakub Filip Turcza   +8 more
doaj   +1 more source

The impact of hyperhidrosis on patients' daily life and quality of life : A qualitative investigation [PDF]

, 2017
Background: An understanding of the daily life impacts of hyperhidrosis and how patients deal with them, based on qualitative research, is lacking.
A. Schouveller, B. Mueller, B. Stacey, C Golics, C Kerr, C Muller, C Pope, CS Cina, D Innocenzi, DL Patrick, DR Strutton, EJ Park, GA Bowen, H Beltraminelli, H Hamm, J Schmidt, J. Halford, JW Creswell, M Amini, M Augustin, M Lupin, M.S. Salek, MK Naumann, MM Chren, N Solish, O Young, P Kamudoni, P. Kamudoni, RA Tupker, SO Lima, SR Tan, T Fujimoto, V Braun, WO Kim, Y Hongbo   +34 more
core   +2 more sources

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

Movement Disorders Clinical Practice, EarlyView.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori, Yohei Mukai, Noriko Nishikawa, Kazuko Hasegawa, Masahiko Tomiyama, Yasuyoshi Kimura, Yoshio Tsuboi, Ryosuke Takahashi, Ryota Nakamura, Yuishin Izumi, Hirohisa Watanabe, Morinobu Seki, Kenji Sekiguchi, Shohei Tateishi, Yusaku Matsushita, Yusaku Nakamura   +15 more
wiley   +1 more source